Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS Blood and Transplant (NHSBT) is seeking to engage with suppliers and manufacturers of Dimethyl Sulphoxide (DMSO) used in the cryopreservation of stem cell and immunotherapy products.
The purpose of this preliminary market engagement is to improve NHSBT's understanding of the current market, available products, supply chain capabilities, packaging options, quality standards, innovation opportunities, and market capacity ahead of a potential future procurement exercise.
The requirement is expected to include sterile, pyrogen-free DMSO with a minimum purity of 99.9%, supplied in a range of formats including vials, bottles, bags and/or syringes suitable for use within NHSBT Cellular and Molecular Therapies laboratories. NHSBT is also interested in understanding supplier capabilities relating to quality assurance, business continuity arrangements, supply resilience, sustainability initiatives, and future product developments.
Preliminary market engagement notice (UK2). The buyer wants to talk to suppliers before designing the procurement. Taking part is how to shape it.
Bids are submitted through the buyer’s own portal, not on this site. Read the full notice on Find a Tender before relying on any date here.
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 Feb 2027 – Feb 2031 | - | planning |